Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Munehiro Kitada

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
Frontiers in Cell and Developmental Biology|August 28, 2020
Mechanism of Activation of Mechanistic Target of Rapamycin Complex 1 by MethionineMunehiro Kitada, Jing Xu, Yoshio Ogura, et al.
Antioxidants (Basel, Switzerland)|November 27, 2021
Exercise Ameliorates Diabetic Kidney Disease in Type 2 Diabetic Fatty RatsItaru Monno, Yoshio Ogura, Jing Xu, et al.
Biomedicines|February 12, 2021
Effect of Methionine Restriction on Aging: Its Relationship to Oxidative StressMunehiro Kitada, Yoshio Ogura, Itaru Monno, et al.
Aging|March 8, 2020
Methionine abrogates the renoprotective effect of a low-protein diet against diabetic kidney disease in obese rats with type 2 diabetesMunehiro Kitada, Yoshio Ogura, Itaru Monno, et al.
Frontiers in Pharmacology|May 1, 2014
N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetesKeizo Kanasaki, Takako Nagai, Kyoko Nitta, et al.
Cureus|December 10, 2025
A Case of Slowly Progressive Type 1 Diabetes Mellitus (SPIDDM, Probable) Successfully Managed With Oral Semaglutide for Glycemic Control and Weight Management Accompanied by Changes in Eating BehaviorTaro Hirai, Munehiro Kitada, Keita Endo, et al.
Current Drug Targets|March 1, 2013
Sirtuins as possible drug targets in type 2 diabetesMunehiro Kitada, Shinji Kume, Keizo Kanasaki, et al.
Clinical Science (London, England : 1979)|October 19, 2012
Sirtuins and renal diseases: relationship with aging and diabetic nephropathyMunehiro Kitada, Shinji Kume, Ai Takeda-Watanabe, et al.
FEBS Open Bio|April 12, 2019
βklotho is essential for the anti-endothelial mesenchymal transition effects of N-acetyl-seryl-aspartyl-lysyl-prolineRongfen Gao, Keizo Kanasaki, Jinpeng Li, et al.
Clinical Science (London, England : 1979)|June 24, 2026
Impact of impaired branched-chain amino acid metabolism on kidney diseaseMunehiro Kitada, Sho Sugahara, Mako Yasuda-Yamahara, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Frontiers in Cell and Developmental Biology|August 28, 2020
Mechanism of Activation of Mechanistic Target of Rapamycin Complex 1 by MethionineMunehiro Kitada, Jing Xu, Yoshio Ogura, et al.
Antioxidants (Basel, Switzerland)|November 27, 2021
Exercise Ameliorates Diabetic Kidney Disease in Type 2 Diabetic Fatty RatsItaru Monno, Yoshio Ogura, Jing Xu, et al.
Biomedicines|February 12, 2021
Effect of Methionine Restriction on Aging: Its Relationship to Oxidative StressMunehiro Kitada, Yoshio Ogura, Itaru Monno, et al.
Aging|March 8, 2020
Methionine abrogates the renoprotective effect of a low-protein diet against diabetic kidney disease in obese rats with type 2 diabetesMunehiro Kitada, Yoshio Ogura, Itaru Monno, et al.
Frontiers in Pharmacology|May 1, 2014
N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetesKeizo Kanasaki, Takako Nagai, Kyoko Nitta, et al.
Cureus|December 10, 2025
A Case of Slowly Progressive Type 1 Diabetes Mellitus (SPIDDM, Probable) Successfully Managed With Oral Semaglutide for Glycemic Control and Weight Management Accompanied by Changes in Eating BehaviorTaro Hirai, Munehiro Kitada, Keita Endo, et al.
Current Drug Targets|March 1, 2013
Sirtuins as possible drug targets in type 2 diabetesMunehiro Kitada, Shinji Kume, Keizo Kanasaki, et al.
Clinical Science (London, England : 1979)|October 19, 2012
Sirtuins and renal diseases: relationship with aging and diabetic nephropathyMunehiro Kitada, Shinji Kume, Ai Takeda-Watanabe, et al.
FEBS Open Bio|April 12, 2019
βklotho is essential for the anti-endothelial mesenchymal transition effects of N-acetyl-seryl-aspartyl-lysyl-prolineRongfen Gao, Keizo Kanasaki, Jinpeng Li, et al.
Clinical Science (London, England : 1979)|June 24, 2026
Impact of impaired branched-chain amino acid metabolism on kidney diseaseMunehiro Kitada, Sho Sugahara, Mako Yasuda-Yamahara, et al.
Pageof 11